API

Active Pharmaceutical Ingredients

OVERVIEW

We began producing Active Pharmaceutical Ingredients (APIs) in 1994 as a vital input in the manufacture of complex formulations and products to facilitate complete vertical integration. Today, our list of APIs exceeds 300 which is used for captive purposes as well as marketed to customers in over 60 countries across the world. Our approach is to offer total solutions to customers by bringing to the table our successful track record, rich experience, unwavering commitment to quality, wide therapeutic range, state-of-the-art research & manufacturing capabilities, and regulatory & intellectual property (IP) expertise.

API PRODUCTSTHERAPEUTIC CATEGORYSPECIFICATIONSCAS NOQUOTE
Clopidogrel Bisulphate Form-IIAnti-ThromboticEP/IP/USP120202-66-6
EtoricoxibAnti-ArthritisUSP/In-House[202409-33-4]
IrbesartanAnti-HypertensiveBP/EP/USP[138402-11-6]
Losartan PotassiumAnti-HypertensiveBP/EP/IP/USP[124750-99-8]
OlanzapineAnti-PsychoticIP/USP[132539-06-1]
OlmesartanAnti HypertensiveBP/EP[144689-63-4]
RisperidoneAnti-PsychoticBP/EP/IP/USP[106266-06-2]
Sodium CromoglycateAnti-InflammatoryBP/EP/IP/USP[15826-37-6]
TelmisartanAnti - HypertensiveBP/EP/USP[144701-48-4]
TopiramateAnti-EpilepticIP/USP[97240-79-4
ValsartanAnti-HypertensiveBP/EP/USP[137862-53-4]

UNDER DEVELOPEMENT

All below products SS Pharma will NOT be supplied to countries in which these could be in conflict with existing patents. The final responsibility lies exclusively with the buyer.

LINAGLIPTIN, PRAMIPEXOLE, HCL, DABIGATRAN, TOLVAPTAN, DORZOLAMIDE, ZILEUTON, GD DOTA, FINASTERIDE, GLIMEPIRIDE

Close Menu